References
- Neild GH. Life expectancy with chronic kidney disease: an educational review. Pediatr Nephrol. 2017; 32:243–8.
- Turin TC, Tonelli M, Manns BJ, Ravani P, Ahmed SB, Hemmelgarn BR. Chronic kidney disease and life expectancy. Nephrol Dial Transplant. 2012; 27:3182–6.
- Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. Clin J Am Soc Nephrol. 2004; 15:1–12.
- Singh NP, Ganguli A, Prakash A. Drug-induced kidney diseases. J Assoc Physicians India. 2003; 51:970–9.
- Taal M, Brenner B. Predicting initiation and progression of chronic kidney disease: developing renal risk scores. Kidney Int. 2006; 70:1694–705.
- Collins AJ, Foley RN, Gilbertson DT, Chen S-C. United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease. Kidney Int Suppl. 2015; 5:2–7.
- Klinkhammer BM, Goldschmeding R, Floege J, Boor P. Treatment of renal fibrosis—turning challenges into opportunities. Adv Chronic Kidney Dis. 2017; 24:117–29.
- El Nahas A, Muchaneta-Kubara E, Essaway M, Soylemezoglu O. Renal fibrosis: insights into pathogenesis and treatment. Int J Biochem Cell Biol. 1997; 29:55–62.
- Ibrahim MY, Hashim NM, Mariod AA, Mohan S, Mahmood AA, Arbab IA. α-Mangostin from Garcinia mangostana Linn: an updated review of its pharmacological properties. Arab J Chem. 2016; 9:317–29.
- Govindachari T, Kalyanaraman P, Muthukumaraswamy N, Pai B. Xanthones of Garcinia mangostana Linn. Tetrahedron. 1971; 27:3919–26.
- Poonkhum R, Watanapokasin R, Pradidarcheep W. Protective effect of alpha-mangostin against type-I collagen formation in thioacetamide-induced cirrhotic rat. J Med Assoc Thai. 2012; 95:S93–8.
- Martínez-Abundis E, García N, Correa F, Hernández-Reséndiz S, Pedraza-Chaverri J, Zazueta C. Effects of α-mangostin on mitochondrial energetic metabolism. Mitochondrion. 2010; 10:151–7.
- Mas VR, Fisher RA, Archer KJ, Maluf DG. Proteomics and liver fibrosis: identifying markers of fibrogenesis. Expert Rev Proteomics. 2009; 6:421–31.
- Moongkarndi P, Jaisupa N, Samer J, Kosem N, Konlata J, Rodpai E, Pongpan N. Comparison of the biological activity of two different isolates from mangosteen. J Pharm Pharmacol. 2014; 66:1171–79.
- Junqueira LCU, Bignolas G, Brentani R. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J. 1979; 11:447–55.
- Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012; 9:671–5.
- Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193:265–75.
- Blum H, Beier H, Gross HJ. Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis. 1987; 8:93–9.
- Jaresitthikunchai J, Phaonakrop N, Kittisenachai S, Roytrakul S. Rapid in-gel digestion protocol for protein identification by peptide mass fingerprint. Proceedings of the 2nd Biochemistry and Molecular Biology Conference: Biochemistry and Molecular Biology for Regional Sustainable Development. 2009 May 7–8, Khon Kaen, Thailand. p. 29.
- Johansson C, Samskog J, Sundström L, Wadensten H, Björkesten L, Flensburg J. Differential expression analysis of Escherichia coli proteins using a novel software for relative quantitation of LC - MS/ MS data. Proteomics. 2006; 6:4475–85.
- Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011; 39(Database issue):D561–8.
- Barker EA, Smuckler EA. Nonhepatic thioacetamide injury: II. The morphologic features of proximal renal tubular injury. Am J Pathol. 1974; 74:575.
- Ghosh S, Sarkar A, Bhattacharyya S, Sil PC. Silymarin protects mouse liver and kidney from thioacetamide induced toxicity by scavenging reactive oxygen species and activating PI3K-Akt pathway. Front Pharmacol. 2016; 7:481. doi: 10.3389/ fphar.2016.00481.
- Adler SG, Schwartz S, Williams ME, Arauz-Pacheco C, Bolton WK, Lee T, et al. Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria. Clin J Am Soc Nephrol. 2010; 5:1420–8.
- Pérez-Rojas JM, Cruz C, García-López P, Sánchez-González DJ, Martínez-Martínez CM, Ceballos G, et al. Renoprotection by α-mangostin is related to the attenuation in renal oxidative/ nitrosative stress induced by cisplatin nephrotoxicity. Free Radic Res. 2009; 43:1122–32.
- Devi Sampath P, Vijayaraghavan K. Cardioprotective effect of α-mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats. J Biochem Mol Toxicol. 2007; 21:336–9.
- Sato A, Fujiwara H, Oku H, Ishiguro K, Ohizumi Y. α-Mangostin induces Ca2+-ATPase-dependent apoptosis via mitochondrial pathway in PC12 cells. Am J Pharmacol Sci. 2004; 95:33–40.
- Safa A. c-FLIP, a master anti-apoptotic regulator. Exp Oncol. 2012; 34:176–84.
- Haag C, Stadel D, Zhou S, Bachem MG, Möller P, Debatin KM, Fulda S. Identification of c-FLIPL and c-FLIPS as critical regulators of death receptor-induced apoptosis in pancreatic cancer cells. Gut. 2011; 60:225–37.
- Safa AR, Day TW, Wu C-H. Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy. Curr Cancer Drug Targets. 2008; 8:37–46.
- Borrelli S, Candi E, Alotto D, Castagnoli C, Melino G, Viganò MA, Mantovani R. p63 regulates the caspase-8-FLIP apoptotic pathway in epidermis. Cell Death Differ. 2009; 16:253–63.
- Schaeffer HJ, Catling AD, Eblen ST, Collier LS, Krauss A, Weber MJ. MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science. 1998; 281(5383):1668–71.
- Jun S, Lee S, Kim H-C, Ng C, Schneider AM, Ji H, et al. PAF-mediated MAPK signaling hyperactivation via LAMTOR3 induces pancreatic tumorigenesis. Cell Rep. 2013; 5:314–22.
- Ma FY, Sachchithananthan M, Flanc RS, Nikolic-Paterson DJ. Mitogen activated protein kinases in renal fibrosis. Front Biosci (Schol Ed). 2009; 1:171–87.
- Banas B, Wörnle M, Berger T, Nelson PJ, Cohen CD, Kretzler M, et al. Roles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis, and tissue homeostasis. J Immunol. 2002; 168:4301–7.
- Zhang H, Sun S-C. NF-κB in inflammation and renal diseases. Cell Biosci. 2015; 5:63. doi: 10.1186/s13578-015-0056-4
- Zhang X, Wang Y, Mao Z, Huang D, Zhou J, Wang X. Expression of NF-kB-inducing kinase in breast carcinoma tissue and its clinical significance. Int J Clin Exp Pathol. 2015; 8:14824–9.
- Choudhary S, Kalita M, Fang L, Patel KV, Tian B, Zhao Y, et al. Inducible tumor necrosis factor (TNF) receptor-associated factor-1 expression couples the canonical to the non-canonical NF-κB pathway in TNF stimulation. J Biol Chem. 2013; 288: 14612–23.
- Ito M, Yoshioka K, Akechi M, Yamashita S, Takamatsu N, Sugiyama K, et al. JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway. Mol Cell Biol. 1999; 19:7539–48.
- Grynberg K, Ma FY, Nikolic-Paterson DJ. The JNK signaling pathway in renal fibrosis. Front Physiol. 2017; 8:829. doi: 10.3389/fphys.2017.00829
- Dhanasekaran D, Kashef K, Lee C, Xu H, Reddy E. Scaffold proteins of MAP-kinase modules. Oncogene. 2007; 26:3185–202.
- Takino T, Nakada M, Miyamori H, Watanabe Y, Sato T, Gantulga D, et al. JSAP1/JIP3 cooperates with focal adhesion kinase to regulate c-Jun N-terminal kinase and cell migration. J Biol Chem. 2005; 280:37772–81.
- Lagares D, Kapoor M. Targeting focal adhesion kinase in fibrotic diseases. BioDrugs. 2013; 27:15–23.